Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
This tie-up will have no impact on any other brands of the company
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Renews GMP certifications for India and Malaysia sites
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated